LONGBOARD PHARMACEUTICALS IN's ticker is LBPH and the CUSIP is 54300N103. A total of 102 filers reported holding LONGBOARD PHARMACEUTICALS IN in Q2 2024. The put-call ratio across all filers is 3.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $4,320 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,118,283 | $6,906 | 0.46% |
| Integral Health Asset Management, LLC | 243,000 | $792,180 | 0.17% |
| FARALLON CAPITAL MANAGEMENT LLC | 810,500 | $2,642,230 | 0.02% |
| BOURGEON CAPITAL MANAGEMENT LLC | 3,500 | $11,410 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 987,712 | $3,121 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 25,000 | $79,000 | 0.00% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1,510,961 | $4,775 | 0.00% |
| UBS Group AG | 971 | $3,165 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| WELLS FARGO & COMPANY/MN | 58 | $189 | 0.00% |